BR9809376A - Pregnan-3-ol-20-onas - Google Patents

Pregnan-3-ol-20-onas

Info

Publication number
BR9809376A
BR9809376A BR9809376-2A BR9809376A BR9809376A BR 9809376 A BR9809376 A BR 9809376A BR 9809376 A BR9809376 A BR 9809376A BR 9809376 A BR9809376 A BR 9809376A
Authority
BR
Brazil
Prior art keywords
pregnan
ones
mammal
onas
pharmaceutically acceptable
Prior art date
Application number
BR9809376-2A
Other languages
English (en)
Inventor
Michael Z Kagan
Syed Muzafar Shah
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of BR9809376A publication Critical patent/BR9809376A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Patente de Invenção: <B>"PREGNAN-3-OL-20-ONAS"<D>. Esta invenção refere-se a um método para proporcionar uma terapia progestacional a um mamífero necessitado dela, que compreende a administração de uma quantidade progestacionalmente eficaz de um sal farmaceuticamente aceitável de éster 3-sulfato de 5<244>-pregnan-3<225>-ol-20-ona ao dito mamífero.
BR9809376-2A 1997-05-02 1998-04-28 Pregnan-3-ol-20-onas BR9809376A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85056797A 1997-05-02 1997-05-02
PCT/US1998/008456 WO1998050042A1 (en) 1997-05-02 1998-04-28 Pregnan-3-ol-20-ones

Publications (1)

Publication Number Publication Date
BR9809376A true BR9809376A (pt) 2000-07-04

Family

ID=25308504

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809376-2A BR9809376A (pt) 1997-05-02 1998-04-28 Pregnan-3-ol-20-onas

Country Status (15)

Country Link
EP (1) EP0981349B1 (pt)
JP (1) JP2001525807A (pt)
KR (1) KR20010012157A (pt)
CN (1) CN1254283A (pt)
AR (1) AR012638A1 (pt)
AT (1) ATE227130T1 (pt)
AU (1) AU739146B2 (pt)
BR (1) BR9809376A (pt)
CA (1) CA2289006A1 (pt)
DE (1) DE69809223T2 (pt)
DK (1) DK0981349T3 (pt)
ES (1) ES2186153T3 (pt)
PT (1) PT981349E (pt)
WO (1) WO1998050042A1 (pt)
ZA (1) ZA983705B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1270718C (zh) * 1998-03-11 2006-08-23 托布乔恩·贝克斯托罗姆 表别孕烷醇酮在制备治疗甾族化合物诱导的疾病的药物中的应用
SE0104423D0 (sv) 2001-12-27 2001-12-27 Umecrine Ab Pregnane steroids and their use in the treatment of CNS disorders
US7572780B2 (en) 2003-01-21 2009-08-11 Dimera, Incorporated Method and kit for reducing the symptoms of peripheral vascular disease
US7473687B2 (en) 2005-03-24 2009-01-06 Emory University Methods for the treatment of a traumatic central nervous system injury
US20090325920A1 (en) 2005-03-24 2009-12-31 Emory University Methods for the treatment of a traumatic central nervous system injury
WO2006117592A1 (en) * 2005-04-29 2006-11-09 Inserm Methods of modulating nuclear receptors
HUE027298T2 (en) 2010-01-14 2016-10-28 Asarina Pharma Ab Pharmaceutical composition containing developed storage and dissolution properties containing 3-beta-hydroxy-5-alpha-pregnan-20-one

Also Published As

Publication number Publication date
DK0981349T3 (da) 2003-03-10
ES2186153T3 (es) 2003-05-01
EP0981349A1 (en) 2000-03-01
PT981349E (pt) 2003-01-31
CN1254283A (zh) 2000-05-24
CA2289006A1 (en) 1998-11-12
JP2001525807A (ja) 2001-12-11
AU739146B2 (en) 2001-10-04
EP0981349B1 (en) 2002-11-06
ZA983705B (en) 1999-11-01
ATE227130T1 (de) 2002-11-15
AU7164798A (en) 1998-11-27
KR20010012157A (ko) 2001-02-15
AR012638A1 (es) 2000-11-08
DE69809223D1 (de) 2002-12-12
DE69809223T2 (de) 2003-07-24
WO1998050042A1 (en) 1998-11-12

Similar Documents

Publication Publication Date Title
BR9811556A (pt) Terapia de combinação compreendendo atorvastatina e um agente anti-hipertensivo
BR9608405A (pt) Composto composi-Æo farmaceutica e processo para tratar um paciente que sofre de um distÚrbio fisiolÄgico
MX9707535A (es) Uso de derivados de vitamina d2 o de vitamina d4 en la preparacion de un farmaco para el tratamiento de hiperparatiroidismo secundario.
BR9807577A (pt) Método para prevenir e retardar o inìcio da doença de alzheimer e sua composição
BR9608587A (pt) Composto que se liga ao receptor de trombopoietina composição farmacêutica e processo para o tratamento de um paciente sofrendo de um distúrbio
DK0998287T3 (da) Anvendelse af levobupivacain
BR9812753A (pt) Combinação farmacêutica, uso da mesma, processo para tratamento de uma doença inflamatória, e, composição farmacêutica
MX9306239A (es) Composicion farmaceutica que forma un gel de lecitina in vivo para la liberacion mantenida de un compuesto biologicamente activo y procedimiento para la preparacion de la misma.
BR9812588A (pt) Métodos e composições farmacêuticas para liberação oral de iodo molecular
ES2150294T3 (es) Composicion de esteres de l-dopa.
BR9707489A (pt) Composto composição farmacêutica e processo para tratar um paciente sofrendo de um distúrbio fisilógico
BR9809951A (pt) Método para tratamento da obesidade
GT199900015A (es) Procedimiento para tratar la insuficiencia cardiaca
BR9909138A (pt) Combinação para o tratamento de dependência de álcool e drogas contendo um antagonista de opióide e um modulador de complexo receptor de nmda
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
BR9809376A (pt) Pregnan-3-ol-20-onas
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
BR9813996A (pt) 2-arilbenzo[b]tiofenos úteis para o tratamento de sìndrome da privação de estrogênio
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
BR9809673A (pt) Derivados de triptolida úteis no tratamento de doenças autoimunes
PT1150681E (pt) Utilizacao de uma composicao farmaceutica que contem desoxipeganina para o tratamento da dependencia da nicotina
BR9814867A (pt) Método para tratar discinesias relacionadas a doenças ou induzidas por drogas
IT1293583B1 (it) Uso dell&#39;acido gammaidrossibutirrico per il trattamento delle sindromi demenziali
BR0004813A (pt) Constructos vesiculares marcados para citoproteção e tratamento de infecções por h. pylori
BR9612355A (pt) Agentes de ligação com os receptores de ácido hialurÈnico e o uso destes.

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A ANUIDADE(S)

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1912 DE 28/08/2007.